Plus Therapeutics Earnings Preview
Portfolio Pulse from Benzinga Insights
Plus Therapeutics (NASDAQ:PSTV) is scheduled to release its quarterly earnings report on March 5, 2024, with an expected EPS of $-1.07. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Shares are currently trading at $1.99, down 56.13% over the last year. Investors are looking for positive guidance for the next quarter.
March 04, 2024 | 6:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Plus Therapeutics is expected to report an EPS of $-1.07 for the upcoming quarter. The company's stock has been down 56.13% over the last year, with investors keenly awaiting future guidance.
Given PSTV's mixed past earnings performance and the significant year-to-date stock decline, the upcoming earnings report and particularly the future guidance will be crucial for short-term stock movement. However, the impact is uncertain due to the mixed historical performance, hence a neutral score.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100